The European Securities and Markets Authority (ESMA) has updated its transparency manual, focusing on two key areas: identifying OTC derivatives subject to transparency requirements and applying the tick-size regime across the EU. If you're responsible for market-structure risk, it's crucial to note that part of this guidance is provisional. Your compliance program must be built with this in mind.
Key Changes in the Update
The update provides guidance on identifying OTC derivatives that fall under transparency requirements and clarifies how reference data for these derivatives should be provided. This aims to ensure consistent data reporting and publication through the consolidated tape. Additionally, it incorporates several published Q&As on the tick-size regime and offers new recommendations on its application, including when trading venues and national authorities may intervene.
The provisional nature of the guidance on OTC identifying reference data is important. The manual should be treated as a draft until the related technical standards, RTS 2 and the RTS on CTP input/output data, come into force. This guidance indicates supervisory direction but is not yet a settled regulatory obligation.
Key Findings
1. Provisional OTC Reference Data Guidance
The guidance is tied to the entry into force of RTS 2 and the RTS on CTP input/output data. Until then, it can change, so treat it as a design input, not a final baseline.
2. Focus on Data Consistency
The manual addresses which OTC derivatives are in scope and how reference data should be supplied. This highlights a data-quality issue. If the same instrument is described differently across reporting parties, the consolidated tape inherits the inconsistency. Expect scrutiny on how you source, normalize, and transmit instrument identifiers.
3. Supervisory Convergence for Tick-Size Regime
The update aims to enhance supervisory convergence in applying the regime. For firms operating across multiple member states, this should reduce divergent national interpretations over time. However, don't assume convergence until it's demonstrated.
4. Defined Intervention Powers
The new recommendations outline when trading venues and authorities may intervene. This introduces a new category of operational exposure. Your trading activity could be affected by actions you didn't initiate or anticipate.
5. Consolidated Q&As
The tick-size Q&As are now part of the manual, providing a single reference point for interpretation. This simplifies your policy gap analysis and means any internal procedures based on standalone Q&As should be rechecked against the current manual.
Implications for Your Team
Two main exposures arise from these findings:
Data Lineage Exposure: Transparency reporting relies on reference data from various sources. If your data map doesn't show where instrument identifiers originate and how they're transformed, you can't ensure consistency. The draft status adds timing risk; a build against today's text may need rework once standards are final.
Conduct and Execution Exposure: The tick-size regime affects how prices are quoted and traded. Intervention scenarios mean your execution risk assessment should consider events outside your control. A scenario analysis that treats tick-size compliance as purely internal will miss these factors.
These exposures likely have different owners. Reference data usually belongs to operations or data management, while tick-size adherence belongs to trading and execution. Ensure neither assumes the other has it covered.
Action Items
Priority 1: Establish Draft-Status Control
Add the dependency on RTS 2 and the RTS on CTP input/output data to your regulatory change register. Assign an owner to track their entry into force and set a trigger to reassess any work built on the draft guidance.
Priority 2: Map OTC Reference Data Flows
Document where identifying reference data for in-scope OTC derivatives originates, who transforms it, and where it's published or transmitted. Flag any point where two systems can produce different values for the same instrument.
Priority 3: Run a Policy Gap Analysis on Tick-Size Procedures
Compare current procedures against the manual, including the consolidated Q&As and new recommendations. Prioritize anywhere your procedures cite a standalone Q&A or an informal national interpretation.
Priority 4: Add Intervention Scenarios to Execution Risk
Build scenarios where a trading venue or national authority intervenes on tick-size grounds. Define who decides, who communicates, and how you evidence your response.
Priority 5: Document Your Interpretation Decisions
Where the guidance leaves room for judgment, record the reasoning, the approver, and the review date. If supervisors later interpret the provision differently, a dated rationale is your best defense.
Priority 6: Reassess When Standards Finalize
Schedule a formal review once the technical standards enter into force. Treat it as a planned event with owners and deadlines.
For more details, check ESMA's website for the current version of the manual and the status of the related technical standards before acting on any specific provision.
